{"id":"https://genegraph.clinicalgenome.org/r/a1d68f1d-9ac3-42c8-b746-a671b54a1eb2v1.0","type":"EvidenceStrengthAssertion","dc:description":"*ADCY5* was first reported in relation to dyskinesia with orofacial involvement in 2012 (Chen et al., PMID: 22782511). Dyskinesia with orofacial involvement is a hyperkinetic movement disorder (more prominent in the face and arms than the legs) characterized by infantile to late-adolescent onset of a combination of chorea, athetosis, dystonia, and myoclonus. Variants in *ADCY5* have been reported in individuals with the following disease entities: autosomal dominant dyskinesia with orofacial involvement (OMIM: 606703), autosomal recessive dyskinesia with orofacial involvement (OMIM: 619647), and autosomal recessive neurodevelopmental disorder with hyperkinetic movements and dyskinesia (OMIM: 619651). The phenotype of affected individuals varies greatly, with overlap between the dominant and recessive cases. Although the recessive cases tend to be more severe than the dominant cases, it is postulated that the severity of phenotypes is related to where the variant is located in the gene rather than the inheritance pattern (PMID: 26537056, 31538084). Variants in the C1b domain generally cause mild phenotypes, while those in the C1a and C2a domain lead to more moderate to severe phenotypes (PMID: 26537056, 31538084). Per criteria outlined by the ClinGen Lumping and Splitting guidance, all three disease entities have been lumped into one disease entity of semi-dominant dyskinesia with orofacial involvement.\n\nSeventeen variants (missense, splice-site, deletion, frameshift) that have been reported in 17 probands from 10 publications (PMIDs: 22782511, 24700542, 25545163, 27052971, 28971144, 27666935, 30975617, 35002175, 33704598, 34631954) are included in this curation. Variants in this gene segregated with disease in at least 22 family members (PMID: 22782511, 26537056, 30975617). More information is available in the literature, but the maximum score for genetic evidence has been reached (12 points). This gene-disease relationship is also supported by functional alteration studies (PMIDs: 30772269). Two knockout mouse models showed contradictory results, so these models were not scored since we are unclear of the relevance of the models (PMIDs: 12223546, 12665504).\n \nIn summary, there is definitive evidence to support the relationship between *ADCY5* and semi-dominant dyskinesia with orofacial involvement. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cerebral Palsy Gene Curation Expert Panel on September 5th, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/a1d68f1d-9ac3-42c8-b746-a671b54a1eb2","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ec58d44e-b258-4ca1-b678-102a9a90678b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ec58d44e-b258-4ca1-b678-102a9a90678b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10113","date":"2024-09-05T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ec58d44e-b258-4ca1-b678-102a9a90678b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10113","date":"2025-07-01T00:08:49.804Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec58d44e-b258-4ca1-b678-102a9a90678b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f3eb65e-d928-4c3a-8092-9580cb6555a3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d6a5f99-b00a-4237-bac2-cd045dd0dab0","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d6a5f99-b00a-4237-bac2-cd045dd0dab0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35002175","allele":{"id":"https://genegraph.clinicalgenome.org/r/94c9041d-9b25-40b5-9278-6bbebb763a69","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.1948-11_1948-2del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2586972842"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2f3eb65e-d928-4c3a-8092-9580cb6555a3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35002175","rdfs:label":"Padmanabha case 2 (2.5 years)","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/94c9041d-9b25-40b5-9278-6bbebb763a69"},"detectionMethod":"Clinical exome sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Generalized choreiform movements continuous at rest; aggravated by action and during intercurrent infections, no exacerbation of movements during sleep","phenotypes":["obo:HP_0000750","obo:HP_0002072","obo:HP_0008936","obo:HP_0004305","obo:HP_0001270"],"previousTesting":true,"previousTestingDescription":"Routine blood examinations were normal. Screening for inborn errors of metabolism was negative. ","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3d6a5f99-b00a-4237-bac2-cd045dd0dab0_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8e80652a-2571-4463-982f-7d79003ed7b5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2101788-4698-40b7-82e4-39e5504f3cee","type":"EvidenceLine","calculatedScore":2.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2101788-4698-40b7-82e4-39e5504f3cee_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No mutated allele could be detected in the patient’s RNA suggesting that this variant induces mRNA degradation, leading to ADCY5 haploinsufﬁciency. Lower amount of ADCY5 transcripts observed in the proband versus controls by 3.4-fold \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c2101788-4698-40b7-82e4-39e5504f3cee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25545163","allele":{"id":"https://genegraph.clinicalgenome.org/r/4926f09b-42a4-45bf-8c2b-51867fda1b31","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.2088+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347808"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/8e80652a-2571-4463-982f-7d79003ed7b5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25545163","rdfs:label":"Carapito proband II.1","allele":{"id":"https://genegraph.clinicalgenome.org/r/4926f09b-42a4-45bf-8c2b-51867fda1b31"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Involuntary choreic movements in the fingers, toes, and face; dystonia affecting all four limbs and the neck; hyperreflexia and extensor plantar responses indicated pyramidal involvement. \n","phenotypes":["obo:HP_0001270","obo:HP_0002359","obo:HP_0030051","obo:HP_0002451","obo:HP_0002072","obo:HP_0004305","obo:HP_0001347","obo:HP_0001332"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c2101788-4698-40b7-82e4-39e5504f3cee_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/0ab0c006-3f8a-4d6b-91cf-7f90dc2e2a85_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ee5e744-3502-444e-bee7-44acd94afdb9","type":"EvidenceLine","dc:description":"A de novo heterozygous N1882S variant in the DOCK3 gene was found in the first patient which could have possibly contributed to the phenotype. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ee5e744-3502-444e-bee7-44acd94afdb9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In vitro functional expression studies showed that mutant R418W caused a significant increase in cAMP production in response to beta-adrenergic stimulation compared to wildtype, consistent with a gain of function \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5ee5e744-3502-444e-bee7-44acd94afdb9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24700542","allele":{"id":"https://genegraph.clinicalgenome.org/r/84da4950-328a-414e-a2c3-4eb89d9e2d45","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.1252C>T (p.Arg418Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347787"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0ab0c006-3f8a-4d6b-91cf-7f90dc2e2a85","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24700542","rdfs:label":"Chen 15 year proband","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":19,"allele":{"id":"https://genegraph.clinicalgenome.org/r/84da4950-328a-414e-a2c3-4eb89d9e2d45"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"myoclonus both at rest and with activity, poor neck support, subtle signs of perioral and periorbital dyskinesia","phenotypes":["obo:HP_0002360","obo:HP_0002509","obo:HP_0001288","obo:HP_0002194","obo:HP_0001260","obo:HP_0001337","obo:HP_0001336","obo:HP_0003327","obo:HP_0001347","obo:HP_0001332","obo:HP_0100660","obo:HP_0007166","obo:HP_0008936"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5ee5e744-3502-444e-bee7-44acd94afdb9_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/18667894-e31d-4b12-9264-ba1bc342b7ef_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5f49e88-02d4-44b2-8532-6c271f6f06e3","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5f49e88-02d4-44b2-8532-6c271f6f06e3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","allele":{"id":"https://genegraph.clinicalgenome.org/r/844d2ab9-4113-4f45-89e3-d0fb36ef9c5d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.3625A>G (p.Met1209Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354222268"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/18667894-e31d-4b12-9264-ba1bc342b7ef","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","rdfs:label":"Zech 53y proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":53,"allele":{"id":"https://genegraph.clinicalgenome.org/r/844d2ab9-4113-4f45-89e3-d0fb36ef9c5d"},"detectionMethod":"High-resolution melting","firstTestingMethod":"PCR","phenotypeFreeText":"Focal (neck)","phenotypes":"obo:HP_0007325","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b5f49e88-02d4-44b2-8532-6c271f6f06e3_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/533a72b8-c44a-4d93-8a41-f4d495cae091_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f2c9add-0c2f-429a-9b48-f1df8ce73417","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f2c9add-0c2f-429a-9b48-f1df8ce73417_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d731940-ed72-4bb4-af71-6a9b0fcff562","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.1196C>T (p.Pro399Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354222676"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/533a72b8-c44a-4d93-8a41-f4d495cae091","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","rdfs:label":"Zech 50y proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":50,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5d731940-ed72-4bb4-af71-6a9b0fcff562"},"detectionMethod":"High-resolution melting ","firstTestingMethod":"PCR","phenotypeFreeText":"Face and neck dystonia","phenotypes":"obo:HP_0007325","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9f2c9add-0c2f-429a-9b48-f1df8ce73417_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c5192c3a-5349-4ec5-a9f1-3183e3b87505_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f67a9203-f234-4059-ba1d-cc5767564ee7","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f67a9203-f234-4059-ba1d-cc5767564ee7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","allele":{"id":"https://genegraph.clinicalgenome.org/r/74e2eb0a-4df3-40f2-855c-d3860179beb2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.3180_3182del (p.Asp1060del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2586973104"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c5192c3a-5349-4ec5-a9f1-3183e3b87505","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","rdfs:label":"Zech 58y proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":58,"allele":{"id":"https://genegraph.clinicalgenome.org/r/74e2eb0a-4df3-40f2-855c-d3860179beb2"},"detectionMethod":"High-resolution melting","firstTestingMethod":"PCR","phenotypeFreeText":"Focal (neck)","phenotypes":"obo:HP_0007325","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f67a9203-f234-4059-ba1d-cc5767564ee7_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fe67b945-f16d-499e-bd0b-29d81244eb15_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12d59a6e-35fc-4a9f-9d3d-925356baeab2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12d59a6e-35fc-4a9f-9d3d-925356baeab2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","allele":{"id":"https://genegraph.clinicalgenome.org/r/c6d93201-963e-4d8f-9c89-d3b2bc9e1d3b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.2180G>A (p.Arg727Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354217898"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fe67b945-f16d-499e-bd0b-29d81244eb15","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","rdfs:label":"Zech 29y proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":29,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c6d93201-963e-4d8f-9c89-d3b2bc9e1d3b"},"detectionMethod":"WES","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Focal (neck)","phenotypes":"obo:HP_0007325","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/12d59a6e-35fc-4a9f-9d3d-925356baeab2_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/74effe98-6fdf-4274-b1cd-9d8fce71b6f5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/246bf1ad-2800-4345-bfcd-2c7e4168e077","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/246bf1ad-2800-4345-bfcd-2c7e4168e077_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28971144","allele":{"id":"https://genegraph.clinicalgenome.org/r/9157de2c-3f53-4669-a4d7-780a88ebcd4c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.409_428del (p.Gly137CysfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658796362"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:BiallelicCompoundHeterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/df215fe5-14f1-4a96-9661-7fdbf0d3d7e3","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df215fe5-14f1-4a96-9661-7fdbf0d3d7e3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28971144","allele":{"id":"https://genegraph.clinicalgenome.org/r/219b68b4-8af5-4f59-af65-4f1dfbfa8fe4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.3037C>T (p.Arg1013Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354224055"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:BiallelicCompoundHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/74effe98-6fdf-4274-b1cd-9d8fce71b6f5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28971144","rdfs:label":"Barrett family proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/9157de2c-3f53-4669-a4d7-780a88ebcd4c"},{"id":"https://genegraph.clinicalgenome.org/r/219b68b4-8af5-4f59-af65-4f1dfbfa8fe4"}],"detectionMethod":"Targeted trio-exome analysis with sanger confirmation\n","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Diagnosed at 3y, Movements lessened with sleep and did not improve with alcohol or caffeine ","phenotypes":["obo:HP_0001336","obo:HP_0004305","obo:HP_0002359","obo:HP_0001332","obo:HP_0031936","obo:HP_0000750","obo:HP_0007325"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/df215fe5-14f1-4a96-9661-7fdbf0d3d7e3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/246bf1ad-2800-4345-bfcd-2c7e4168e077_variant_evidence_item"}],"zygosity":{"id":"cg:BiallelicCompoundHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/6c914297-ebe8-4284-a0ca-c1a3f085620d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11c84012-fd7e-4a69-b7e4-647f1bd64503","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11c84012-fd7e-4a69-b7e4-647f1bd64503_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9efe6d8-e271-4f03-bdf8-851a984d9106","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.1400A>G (p.Asn467Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354221626"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6c914297-ebe8-4284-a0ca-c1a3f085620d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","rdfs:label":"Zech 26y proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":26,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c9efe6d8-e271-4f03-bdf8-851a984d9106"},"detectionMethod":"High-resolution melting","firstTestingMethod":"PCR","phenotypeFreeText":"Focal (neck)","phenotypes":"obo:HP_0007325","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/11c84012-fd7e-4a69-b7e4-647f1bd64503_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/321126a6-f429-4dee-82ca-ddf1f404e277_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ce97a33-1469-4eb0-ba5d-b4a568ef7dd5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ce97a33-1469-4eb0-ba5d-b4a568ef7dd5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In vitro functional expression studies showed that mutant R418W caused a significant increase in cAMP production in response to beta-adrenergic stimulation compared to wildtype, consistent with a gain of function \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4ce97a33-1469-4eb0-ba5d-b4a568ef7dd5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24700542","allele":{"id":"https://genegraph.clinicalgenome.org/r/84da4950-328a-414e-a2c3-4eb89d9e2d45"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/321126a6-f429-4dee-82ca-ddf1f404e277","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24700542","rdfs:label":"Chen 18 year proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/84da4950-328a-414e-a2c3-4eb89d9e2d45"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Choreoathetosis and dystonia most prominent at rest and were alleviated by physical activity","phenotypes":["obo:HP_0001332","obo:HP_0001266","obo:HP_0000317","obo:HP_0001260"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4ce97a33-1469-4eb0-ba5d-b4a568ef7dd5_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/77355e80-32e3-4a88-b677-645aec539800_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6d01a9f-4e2e-4639-9466-a5f803e8a63f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6d01a9f-4e2e-4639-9466-a5f803e8a63f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","allele":{"id":"https://genegraph.clinicalgenome.org/r/10dde8b5-2e4c-4f64-90ab-07e702181e08","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.1378A>T (p.Ile460Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354221681"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/77355e80-32e3-4a88-b677-645aec539800","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666935","rdfs:label":"Zech patient 16","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":{"id":"https://genegraph.clinicalgenome.org/r/10dde8b5-2e4c-4f64-90ab-07e702181e08"},"detectionMethod":"Clinical exome sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"permanent heel walking, upgoing plantar reﬂexes, phasic retro- and laterocollis","phenotypes":["obo:HP_0002530","obo:HP_0001332","obo:HP_0001288","obo:HP_0001336","obo:HP_0001260","obo:HP_0001270","obo:HP_0000643","obo:HP_0100703","obo:HP_0100660","obo:HP_0002356"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c6d01a9f-4e2e-4639-9466-a5f803e8a63f_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/257b4c54-ad79-4266-88f1-2afdd919fbff_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9ed91bd-8f6e-4f3f-9e1e-602fca38f7d4","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9ed91bd-8f6e-4f3f-9e1e-602fca38f7d4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"cAMP assay showed significantly enhanced cAMP production compared to wildtype (PMID: 30772269)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d9ed91bd-8f6e-4f3f-9e1e-602fca38f7d4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27052971","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e001525-4390-457a-b451-1e0f000a1dad","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.2080_2088del (p.Lys694_Met696del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499216418"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/257b4c54-ad79-4266-88f1-2afdd919fbff","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27052971","rdfs:label":"Dy Patient 1 (3 years)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1e001525-4390-457a-b451-1e0f000a1dad"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Continuous hyperkinesia and choreoathetosis, significantly delayed development (cannot sit or\nroll over, significant head lag), Orolingual dyskinesias","phenotypes":["obo:HP_0001260","obo:HP_0001252","obo:HP_0001266","obo:HP_0002487","obo:HP_0001263","obo:HP_0002540","obo:HP_0001344","obo:HP_0100543","obo:HP_0100660"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d9ed91bd-8f6e-4f3f-9e1e-602fca38f7d4_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1beaad3b-446e-4649-b78e-13e8b3004619_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e01dd049-014c-4ec8-ad6b-0135d8ee99c4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e01dd049-014c-4ec8-ad6b-0135d8ee99c4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In vitro functional expression studies showed that mutant A726T caused a significant increase in cAMP production in response to beta-adrenergic stimulation compared to wildtype, consistent with a gain of function (Chen et al. 2014, PMID: 24700542)\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e01dd049-014c-4ec8-ad6b-0135d8ee99c4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22782511","allele":{"id":"https://genegraph.clinicalgenome.org/r/44e7bb07-1bde-4d71-9cb1-9fa28a2047fb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.2176G>A (p.Ala726Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342901"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1beaad3b-446e-4649-b78e-13e8b3004619","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22782511","rdfs:label":"Chen 2012 proband V-3","allele":{"id":"https://genegraph.clinicalgenome.org/r/44e7bb07-1bde-4d71-9cb1-9fa28a2047fb"},"detectionMethod":"arrayCGH revealed no pathogenic CNVs. Variants identified were confirmed by Sanger sequencing","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Predominantly perioral and periorbital myokymia, and face, neck and upper limb dystonic/choreic movements \n","phenotypes":["obo:HP_0000317","obo:HP_0002268","obo:HP_0002072","obo:HP_0001332"],"secondTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e01dd049-014c-4ec8-ad6b-0135d8ee99c4_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ec58d44e-b258-4ca1-b678-102a9a90678b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f1c4b6a-797b-4833-941b-232c5d283afa_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30975617","rdfs:label":"Bohlega family","estimatedLodScore":3.26,"family":{"id":"https://genegraph.clinicalgenome.org/r/0f1c4b6a-797b-4833-941b-232c5d283afa","type":"Family","rdfs:label":"Bohlega family","member":{"id":"https://genegraph.clinicalgenome.org/r/2017a44d-02ef-4add-b8e3-c51c6c150e5a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30975617","rdfs:label":"Bohlega proband IV.2 (20 years)","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/cb134982-8851-4a94-8e0a-cd11f8f14adc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.1762G>A (p.Asp588Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354219489"}},"detectionMethod":"homozygosity mapping and WES with Sanger confirmation","firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_6000029","obo:HP_0001824","obo:HP_0000750","obo:HP_0001260","obo:HP_0001288","obo:HP_0001336","obo:HP_0011468","obo:HP_0001332","obo:HP_0000821","obo:HP_0008936","obo:HP_0001638","obo:HP_0001270","obo:HP_0000737"],"secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1809e301-ccb1-47bb-82a4-cf9fb2e516f3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30975617","allele":{"id":"https://genegraph.clinicalgenome.org/r/cb134982-8851-4a94-8e0a-cd11f8f14adc"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Autosomal recessive"},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0011468","obo:HP_0001288","obo:HP_0008763","obo:HP_0008936","obo:HP_0001270","obo:HP_0001337","obo:HP_0001260","obo:HP_0001638","obo:HP_0000750","obo:HP_0001332","obo:HP_0000737","obo:HP_6000029","obo:HP_0001336","obo:HP_0001824","obo:HP_0000821"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2017a44d-02ef-4add-b8e3-c51c6c150e5a"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/6e69ed5e-1469-4864-9f0e-75e78e8c7ec5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22782511","rdfs:label":"Chen 2012 family","estimatedLodScore":2.71,"family":{"id":"https://genegraph.clinicalgenome.org/r/6e69ed5e-1469-4864-9f0e-75e78e8c7ec5","type":"Family","rdfs:label":"Chen 2012 family","member":{"id":"https://genegraph.clinicalgenome.org/r/1beaad3b-446e-4649-b78e-13e8b3004619"},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypeFreeText":"Predominantly perioral and periorbital myokymia, and face, neck and upper limb dystonic/choreic movements \n","phenotypePositiveAllelePositive":10,"phenotypes":["obo:HP_0001332","obo:HP_0001635","obo:HP_0000317","obo:HP_0002268","obo:HP_0001644","obo:HP_0002072"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1beaad3b-446e-4649-b78e-13e8b3004619"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/fe3dcc2a-0593-411a-979d-fbb1d44e1b39_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26537056","rdfs:label":"Chen 2015 family EHC","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/fe3dcc2a-0593-411a-979d-fbb1d44e1b39","type":"Family","rdfs:label":"Chen 2015 family EHC","cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotype":[{"id":"obo:HP_0011468"},{"id":"obo:HP_0002072"},{"id":"obo:HP_0006801"}],"phenotypeFreeText":"Episodic jerky movements of the face, upper extremities, and feet which worsened with stress, were socially embarrassing","phenotypePositiveAllelePositive":8,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/3412a3a0-0da6-4a3b-a242-1cf60a0a49b5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7586c4e-a9df-43ce-9454-7bc19a3b65cc","type":"EvidenceLine","dc:description":"Downgraded for homozygosity and consanguinity.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7586c4e-a9df-43ce-9454-7bc19a3b65cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34631954","allele":{"id":"https://genegraph.clinicalgenome.org/r/3dfb3023-9eb7-4c19-bdcd-6c628c368499","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.1947+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354219064"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3412a3a0-0da6-4a3b-a242-1cf60a0a49b5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34631954","rdfs:label":"Kaiyrzhanov proband III.5","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3dfb3023-9eb7-4c19-bdcd-6c628c368499"},"detectionMethod":"homozygosity mapping, exome sequencing and confirmed by Sanger sequencing","firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0034353","obo:HP_0001263","obo:HP_0008770","obo:HP_0002487","obo:HP_0033725","obo:HP_0004305","obo:HP_0008936","obo:HP_0010864","obo:HP_0007321","obo:HP_0011468","obo:HP_0000496","obo:HP_0001510","obo:HP_0002119","obo:HP_0000817","obo:HP_5200232","obo:HP_0001332","obo:HP_0100660","obo:HP_0001336","obo:HP_0002540","obo:HP_0003763","obo:HP_0000739","obo:HP_0001344","obo:HP_0001337"],"secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f7586c4e-a9df-43ce-9454-7bc19a3b65cc_variant_evidence_item"},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b1042673-4baf-4783-ba56-265db90fab43_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a2c9dc7a-b14b-4da4-a649-83c0fea4ad80","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a2c9dc7a-b14b-4da4-a649-83c0fea4ad80_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"cAMP assay showed significantly enhanced cAMP production compared to wildtype (PMID: 30772269)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a2c9dc7a-b14b-4da4-a649-83c0fea4ad80_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35002175","allele":{"id":"https://genegraph.clinicalgenome.org/r/83355f1a-59a4-4a02-98c6-c73c2c2d5db6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.1253G>A (p.Arg418Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347806"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b1042673-4baf-4783-ba56-265db90fab43","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35002175","rdfs:label":"Padmanabha case 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/83355f1a-59a4-4a02-98c6-c73c2c2d5db6"},"detectionMethod":"Targeted exome analysis with sanger confirmation\n","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"perioral dyskinesia, multifocal myoclonus (face and limbs), choreiform movements of limbs; worsening with stress. Generalized choreiform movements at rest and increasing on action\n","phenotypes":["obo:HP_0011968","obo:HP_0008936","obo:HP_0100543","obo:HP_0001263","obo:HP_0003593","obo:HP_0001336","obo:HP_0100660","obo:HP_0001332","obo:HP_0025732","obo:HP_0001266","obo:HP_0003680"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a2c9dc7a-b14b-4da4-a649-83c0fea4ad80_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2017a44d-02ef-4add-b8e3-c51c6c150e5a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1809e301-ccb1-47bb-82a4-cf9fb2e516f3","type":"EvidenceLine","dc:description":"Downgraded for homozygosity and consanguinity.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1809e301-ccb1-47bb-82a4-cf9fb2e516f3_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.05},{"id":"https://genegraph.clinicalgenome.org/r/2017a44d-02ef-4add-b8e3-c51c6c150e5a"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.05},{"id":"https://genegraph.clinicalgenome.org/r/c4aad24f-5cba-45fa-87a4-dbc8582b00c3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dec97404-2880-405c-8a3d-4aabd29f3a3c","type":"EvidenceLine","dc:description":"Downgraded for homozygosity","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dec97404-2880-405c-8a3d-4aabd29f3a3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33704598","allele":{"id":"https://genegraph.clinicalgenome.org/r/50c8e9b9-4455-4da1-b7c6-cd442a8e9726","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_183357.3(ADCY5):c.3712C>T (p.Arg1238Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354222041"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.05},{"id":"https://genegraph.clinicalgenome.org/r/c4aad24f-5cba-45fa-87a4-dbc8582b00c3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33704598","rdfs:label":"Okamoto proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/50c8e9b9-4455-4da1-b7c6-cd442a8e9726"},"detectionMethod":"WES","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"sudden movements when surprised, agitation in response to sounds and touch","phenotypes":["obo:HP_0001263","obo:HP_0010864","obo:HP_0000713","obo:HP_0000750","obo:HP_0008936","obo:HP_0003593","obo:HP_0011968","obo:HP_0001510","obo:HP_0001347","obo:HP_0032989","obo:HP_0002533","obo:HP_0000817","obo:HP_0002421","obo:HP_0001332"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/dec97404-2880-405c-8a3d-4aabd29f3a3c_variant_evidence_item"},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.05}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/ec58d44e-b258-4ca1-b678-102a9a90678b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec58d44e-b258-4ca1-b678-102a9a90678b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35f1f5c1-5d68-4bed-a627-26628382e6b0","type":"EvidenceLine","dc:description":"No movement disorders were observed in the null mouse","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc2d735f-e2c6-4914-959b-00a929077208","type":"Finding","dc:description":"AC5−/− mice were active in their home cage with normal spontaneous general motor activities and morphologically indistinguishable from their wild-type. However, AC5 mRNA expression was negated and AC activity in AC5−/− was reduced to 18% in the striatum, 73% in the cerebral cortex, and 60% in the cerebellum of that in wildtype. Disruption of AC5 eliminated >80% of forskolin-induced AC activity and 85–90% of AC activity stimulated by either D1 or A2A receptor agonists in striatum. The signal cascade from D2 to AC was also completely abolished in AC5−/− suggesting that AC5 is the physiologically relevant AC for D2 receptors.\n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12223546","rdfs:label":"Lee KO mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/507721ab-2fd7-4e50-8ae3-46cc6c6f1cd6","type":"EvidenceLine","dc:description":"Although the null mouse showed movement disorders, a previous knockout mouse showed no phenotypes. The clinical relevance of this model is unclear at this point","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b3f44ee-c89b-495e-b0f6-9e472ec852f4","type":"Finding","dc:description":"AC5−/− mice exhibited Parkinsonian-like motor dysfunction. Abnormal coordination was detected by Rotarod test, bradykinesia detected by pole test, and slight locomotor impairment detected by open field tests. Mutants also showed decreased rearing actions in the home cage. Major impairment was seen in AC5−/− and to a lesser degree in the heterozygous mice relative to WT. Selective D1 or D2 dopaminergic stimulation improved only coordination or locomotion, respectively suggesting that other ACs present in striatum, including the highly homologous AC6, cannot fully replace the functions of AC5\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12665504","rdfs:label":"Iwamoto KO mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ec58d44e-b258-4ca1-b678-102a9a90678b_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de56a624-b1e9-4a95-98b4-5e78d973c8b5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2b76a81-c8de-499b-8a58-88c3cbd4f8c5","type":"FunctionalAlteration","dc:description":"AC5 mutants exhibit enhanced activity to Gαs-mediated stimulation in both cell and membrane-based assays. Whereas the mutants cyclases are more weakly inhibited by Gαi/o-coupled receptors following D2 dopamine receptor activation. This potentially shifts the delicate balance of intracellular cAMP signaling within the neural circuitry of the striatum. Patients expressing AC5 gain-of-function variants may have enhanced direct pathway activity, in combination with reduced disinhibition from the D2R-mediated indirect pathway. This loss of cooperative activity in both direct and indirect pathways likely results in an unsynchronized enhancement of movement initiation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30772269","rdfs:label":"Doyle functional alteration"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Definitive","sequence":10741,"specifiedBy":"GeneValidityCriteria10","strengthScore":12.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/iqbLeTwTfw0","type":"GeneValidityProposition","disease":"obo:MONDO_0031115","gene":"hgnc:236","modeOfInheritance":"obo:HP_0032113"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ec58d44e-b258-4ca1-b678-102a9a90678b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}